Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.9700
-0.0200 (-2.02%)
Jan 20, 2026, 10:06 AM EST
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $60.99 million as of January 23, 2026. Its market cap has decreased by -29.91% in one year.
Market Cap
60.99M
Enterprise Value
62.82M
Revenue
-62.11K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.97
Market Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has increased from 33.63M to 60.99M, an increase of 81.38%. That is a compound annual growth rate of 4.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 62.37M | 5.48% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HST Global | 131.71M |
| BioStem Technologies | 88.84M |
| Nuo Therapeutics | 75.80M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 43.94M |
| Oncotelic Therapeutics | 39.59M |
| LakeShore Biopharma | 34.82M |
| ZIVO Bioscience | 33.07M |